RSY Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index

Recom Managed Systems, Inc. (AMEX:RSY), a life-sciences company developing patented heart-monitoring technology, today announced the appointments of three key executives to its growing management team. Jane Greene joins the company as the vice president of market development; Claire Mouton LaFrance joins as director of marketing and communications; and Stan Gelfer as director of information systems. "We're excited to welcome Jane, Claire and Stan to spearhead the development of Recom's marketing and management information systems (MIS) organizations," said Pamela Bunes, president and chief executive officer of Recom. "Jane's background in the medical-monitoring industry will be a great asset as we seek to commercialize our proprietary technology, and Claire's expertise in physician relations and communications will be invaluable as we move to establish this technology with the medical community. Furthermore, Stan's expertise in project management and MIS development is already proving critical to the creation of our infrastructure." Prior to joining the company, Ms. Greene founded two medical-monitoring companies, serving as chief executive officer, president and chairman of the board for both Monitor Medx, a cardiac-monitoring company, and Medical Resource Management, a perinatal home monitoring company. Most recently, Ms. LaFrance was employed as corporate sales manager and physician liaison for Greenville Hospital System. In these roles, she established, staffed and trained the sales department; negotiated acquisitions of private physician practices by the hospital system; and served as intermediary between physicians and hospital administration. She also was responsible for public relations activities, including planning and execution of community events. Mr. Gelfer was previously a senior project manager of strategic business development at Countrywide Financial Services, Inc. He has held senior MIS positions at several corporations, including Amgen, Warner Brothers and Disney. "Recom's Model 100 Heart Monitor has the potential to transform the way physicians diagnose and treat cardiac patients," said Ms. Bunes. "I look forward to working with this outstanding team of professionals as we work to build a successful launch and marketing program for this innovative technology." Breakthrough ECG Monitoring Technology Recom's first product, the Model 100 Heart Monitor, is an ambulatory patient heart monitor that uses patented signal-processing technology to record a clinical-quality ECG signal in the presence of "noise," or interference, generated by the patient's body movements and ambient environment. By reducing these interfering factors during recordings, the Recom Model 100 helps family practitioners, internists and cardiologists more accurately detect cardiac abnormalities or changes that may occur during daily activities and allows medical experts to collect extensive, continuous cardiac data over time, which can establish a baseline against which future readings can be compared. The Model 100 provides up to 48 hours of real-time heart monitoring during patients' everyday activities. The Model 100 has received 510(k) clearance from the Food and Drug Administration. About Recom Managed Systems, Inc. Recom Managed Systems, Inc. is an emerging life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With our patented signal-technology platform, Recom brings clinical-quality physiological signal monitoring to the ambulatory setting. Recom Managed Systems, Inc. has its corporate headquarters in Greenville, S.C., and research and development facilities in Studio City, Calif. Recom is traded on the American Stock Exchange under the symbol RSY. More information is located at http://www.recom-systems.com. Caution Regarding Forward-Looking Statements Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity-market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.